Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
11/2013
11/27/2013CN102342940B Process for preparation of anti-tubercular combination and pharmaceutical composition prepared therefrom
11/27/2013CN102321102B N2,N4-disubstituted-2H,4H-pyrrole[1,2-b][1,2,4,6] thiatriazine-1,1,3-triketone derivatives as well as preparation and application thereof
11/27/2013CN102062758B Impurity analysis and preparation method for clindamycin phosphate
11/27/2013CN102010420B [(10S)-9,10-dihydroartemisinine-10-oxyl]benzaldehyde semicarbazones (sulfur) series substances as well as preparation method and application thereof
11/27/2013CN102007132B Crystalline (6R,7R)-7-{2-(5-amino-[1,2,4]thiadiazol-3-yl)-2-[(z)-trityloxyimino]-acetylamino}-3-[(r)-1'-tert-butoxycarbonyl-2-oxo-[1,3']bipyrrolidinyl-(3E)-ylidenemethyl]-8-oxo-5-thia-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid benzhydryl ester, preparation and use thereof
11/27/2013CN101998990B Improvements in preparation of influenza virus vaccine antigens
11/27/2013CN101502492B Method for preparing clarithromycin granule without bitter taste
11/26/2013US8592395 Therapeutic compounds
11/26/2013US8592375 Multifunctional context-activated protides and methods of use
11/26/2013US8592367 Nodule specific medicago peptides having antimicrobial activity and pharmaceutical compositions containing the same
11/26/2013US8592196 Modified influenza virus
11/26/2013US8591950 Hydrogel implants with varying degrees of crosslinking
11/26/2013US8591908 Immunogen for preparation of therapeutic vaccines or drugs for treatment of hepatitis B and the producing method and use thereof
11/26/2013CA2511538C Immunostimulatory combinations
11/26/2013CA2448971C Chimeric flavivirus vectors
11/26/2013CA2378562C Method for producing oligopolysaccharides
11/26/2013CA2334850C Novel methods and interferon deficient substrates for the propagation of viruses
11/21/2013WO2013173519A1 Beta-lactamase substrates and methods of their use for the diagnosis of tuberculosis
11/21/2013WO2013173492A1 Antiviral compounds with an imidazole - biphenyl - imidazole core
11/21/2013WO2013172922A1 Lmtk3 genotype analysis for use in predicting outcome and therapy selection
11/21/2013WO2013172918A1 Ksr1 gene polymorphism for use in predicting outcome and therapy selection
11/21/2013WO2013172732A1 Complex compounds of germanium, methods for producing same, and drugs
11/21/2013WO2013172725A1 The use of chitosan polymer in the treatment and prevention of infections caused by coronaviruses
11/21/2013WO2013172714A1 Treatment of conditions associated with mycotoxin exposure
11/21/2013WO2013172479A1 Carboxylic acid compounds
11/21/2013WO2013172087A1 Composition provided with nitric oxide production-inhibiting activity
11/21/2013WO2013171694A1 Fluorinated bridged spiro[2.4]heptane derivatives as alx receptor agonists
11/21/2013WO2013171642A1 Benzamide derivatives for inhibiting the activity of abl1, abl2 and bcr-abl1
11/21/2013WO2013171607A1 Vaginal cream for the treatment of papilloma infection comprising docosanol, turmeric, amla and aloe
11/21/2013WO2013171334A1 Methanethione compounds having antiviral activity
11/21/2013WO2013171307A1 N-methyl-4-benzylcarbamidopyridinium chloride and a process for its preparation
11/21/2013WO2013171281A1 Hydantoin and thiohydantoin derivatives as antiviral drugs
11/21/2013WO2013171164A1 Compositions and formulations for the treatment of halitosis
11/21/2013WO2013170985A1 New aminoglycoside antibiotics targeting bacterial 16s ribosomal rna lacking ototoxicity
11/21/2013WO2013170901A1 N-methyl-4-benzylcarbamidopyridinium chloride and a process for its preparation
11/21/2013WO2013170735A1 Method for treating and/or preventing lung injury
11/21/2013WO2013170386A1 Oligonucleotide chelate complex-polypeptide compositions and methods
11/21/2013WO2013170385A1 Oligonucleotide chelate complex methods
11/21/2013WO2013122513A3 Nanobodies which bind to the chlamydia trachomatis antigen and method for inhibiting infection caused by chlamydia trachomatis
11/21/2013US20130310388 Modulators of TNF-Alpha Signaling
11/21/2013US20130310336 Methods and compositions for treating flaviviruses and pestiviruses
11/21/2013US20130310335 Prolonged release bioadhesive therapeutic systems
11/21/2013US20130310320 Boronic ester and acid compounds, synthesis and uses
11/21/2013US20130309268 Compositions including transfer factor derived from eggs
11/21/2013US20130309232 Vascular endothelial growth factor 2
11/21/2013US20130309215 Pharmaceutical composition
11/21/2013US20130309179 Synthetic peptide constructs for the diagnosis and treatment of periodontis associated with porphyromonas gingivalis
11/20/2013EP2664621A1 Antiviral agent
11/20/2013EP2664618A2 Chemokine receptor modulators
11/20/2013EP2664616A1 Hydantoin and thiohydantoin derivatives as antiviral drugs
11/20/2013EP2664614A1 Palladium-copper catalysts for the homogeneous selective oxidation of thiol groups
11/20/2013EP2664318A1 Antimicrobially active compositions based on zinc compound, glycerine monoalkyl ether and antioxidant
11/20/2013EP2663562A1 Solid forms of gyrase inhibitor (r)-1-ethyl-3-[6-fluoro-5-[2-(1-hydroxy-1-methyl-ethyl) pyrimidin-5-yl]-7-(tetrahydrofuran-2-yl)-1h-benzimidazol-2-yl]urea
11/20/2013EP2663557A1 Pyrimidine gyrase and topoisomerase iv inhibitors
11/20/2013EP2663338A2 Oligosaccharide conjugates for targeting bacteria and uses related thereto
11/20/2013EP2663337A2 Method for delivering agents into cells using bacterial toxins
11/20/2013EP2663334A2 Antibodies directed against influenza
11/20/2013EP2663322A2 New uses of cyclophilin inhibitors
11/20/2013EP2663289A2 Cefpodoxime proxetil formulations comprising taste regulating agent
11/20/2013EP2411047B1 Vaccine for protection against streptococcus suis bacteria of various serotypes
11/20/2013EP2340022B1 Combination therapy for tuberculosis
11/20/2013EP2108655B1 Immune-modulating peptide
11/20/2013EP1951708B1 Piperazine derivative useful as a ccr5 antagonist
11/20/2013EP1904067B1 Pharmaceutical formulation of carboxamide hiv integrase inhibitors containing a release rate controlling composition
11/20/2013EP1709044B2 Oxazolidinone-quinolone hybrid antibiotics
11/20/2013EP1690545B1 Preparation of Product R and product so obtained
11/20/2013EP1651762B1 Small interfering rna specific to sub-units alpha, alpha' and beta of the kinase protein ck2, and the applications of the same
11/20/2013EP1613628B1 Reversible inhibitors of s-adenosyl-l-homocysteine hydrolase and uses thereof
11/20/2013CN103403014A O-(replaced benzyl)phosphoramidate and use thereof
11/20/2013CN103403009A Macrocyclic inhibitors of flaviviridae viruses
11/20/2013CN103403000A Solid forms of gyrase inhibitor (R)-1-ethyl-3-[6-fluoro-5-[2-(1-hydroxy-1-methyl-ethyl) pyrimidin-5-yl]-7-(tetrahydrofuran-2-yl)-1h-benzimidazol-2-yl]urea
11/20/2013CN103402998A Bifunctional molecules with antibody-recruiting and entry inhibitory activity against the human immunodeficiency virus
11/20/2013CN103402973A Compound and method for producing same, as well as method for producing oseltamivir phosphate
11/20/2013CN103402544A Conjugation process
11/20/2013CN103402543A Azole pharmaceutical formulations for parenteral administration and methods for preparing and using the same as treatment of diseases sensitive to azole compounds
11/20/2013CN103397031A siRNA compositions and methods for potently inhibiting viral infection
11/20/2013CN103397000A Human diploid cell adapted strain of rabies virus and preparation method and application thereof
11/20/2013CN103396999A H9N2 subtype virus, H9N2 subtype virus vaccine and preparation method thereof
11/20/2013CN103396975A Vector pSVK based hepatitis B therapeutic plasmid DNA vaccine fermentation production method, and special engineering bacterium and high-yield fermentation culture medium therefor
11/20/2013CN103396495A Fusion protein comprising Fc receptor binding polypeptide and antigenic polypeptide and used for mediateimmune response
11/20/2013CN103396476A Two cyclic hexapeptide compounds and application thereof in preparation of antibacterial drug
11/20/2013CN103396474A APJ receptor compound
11/20/2013CN103396473A Cxcr4 receptor compound
11/20/2013CN103396471A Metal beta-lactamase inhibitory peptide and application thereof
11/20/2013CN103396453A Pharmaceutical use of Pradefovir
11/20/2013CN103396415A Novel substituted imidazoquinolines
11/20/2013CN103396396A Amido alkyl acyl clinafloxacin and application thereof
11/20/2013CN103396389A Naphthoquinone sesquiterpenes compound and application thereof in preparation of anti-tumour or antibacterial medicine
11/20/2013CN103396376A Anti-bacterial and anti-cancer active compound
11/20/2013CN103394331A Hepatitis c virus adsorbent as well as preparation method and application thereof
11/20/2013CN103394098A Application of expression vector of natural killer cell enhancement factor (NKEF) of turbot
11/20/2013CN103394097A Primers of transmissible gastroenteritis-porcine epidemic diarrhea combined vaccine and preparation method
11/20/2013CN103394096A Novel viral vector
11/20/2013CN103394084A Immunoglobulin G (IgG) concentrate depleted of anti-A and anti-B antibodies and of polyreactive IgGs
11/20/2013CN103394082A Multivalent immunogenic composition
11/20/2013CN103394081A Method for producing avian influenza vaccine by using WAVE bioreactor
11/20/2013CN103394080A Vaccination of young animals against lawsoniaintracellularis infections
11/20/2013CN103394078A Self-pressurized multi-target collaborative hemostasis degradable hemostatic preparation for injury first aid
11/20/2013CN103394074A Cyclic antimicrobial peptides
11/20/2013CN103394070A Chinese medicine preparation for treating influenza
1 ... 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 ... 1798